论文部分内容阅读
目的:对重组人干扰素α-2b阴道泡腾胶囊对宫颈糜烂的治疗效果进行研究分析。方法:选取62例宫颈糜烂患者按照治疗方法分为两组(各31例),一组为治疗组,一组为对照组。结果:治疗组患者临床治疗总有效率显著高于对照组患者(96.77%和74.19%),差异有显著性(P<0.05);两组患者不良反应发生率相比,差异无显著性(P>0.05)。结论:在治疗宫颈糜烂临床上重组人干扰素α-2b阴道泡腾胶囊效果显著,且不良反应较少。
Objective: To study the therapeutic effect of recombinant human interferon α-2b vaginal effervescent capsules on cervical erosion. Methods: 62 patients with cervical erosion were divided into two groups (31 in each group) according to the treatment method. One group was treatment group and the other was control group. Results: The total effective rate of clinical treatment in the treatment group was significantly higher than that in the control group (96.77% and 74.19%, respectively) (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion: The clinical efficacy of recombinant human interferon α-2b vaginal effervescent capsules in the treatment of cervical erosion is remarkable with less adverse reactions.